Nutraceutical manufacturer Kelker Pharma Inc on Tuesday announced the launch of its first branded nutritional supplement system to promote better health and ease discomforts from the use of GLP-1 medications.

NUTRILINQ, a comprehensive, physician-formulated nutritional support system, is the first of its kind designed to complement GLP-1 receptor agonist medications such as Ozempic, Wegovy and Mounjaro.

The company said that NUTRILINQ is based on extensive research and clinical expertise, developed to meet the specific requirements of individuals on GLP-1 medications who are losing weight rapidly from caloric deprivation. It includes three distinct products, designed for ease of use and specifically beneficial for GLP-1 medication users who often experience irritable gut and nausea. It also addresses other common pain points related with rapid weight loss, including bloating, fatigue, compromised immune system, brittle nails, hair loss and muscle deterioration.

Dr. Tariq Kelker, MD, Kelker Pharma founder and chairman, said: "NUTRILINQ represents a significant advancement in supporting patients throughout their GLP-1 treatment journey. Our team of doctors and formulators have created a system that directly addresses the side effects and nutritional deficits associated with rapid weight loss from GLP-1 use."